Rockland Trust’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1M | Buy |
77,979
+13,255
| +20% | +$2.9M | 0.83% | 40 |
|
|
2025
Q1 | $14.5M | Buy |
64,724
+4,980
| +8% | +$1.11M | 0.73% | 44 |
|
|
2024
Q4 | $19.6M | Buy |
59,744
+3,102
| +5% | +$1.02M | 1% | 34 |
|
|
2024
Q3 | $17M | Buy |
56,642
+3,055
| +6% | +$917K | 0.84% | 41 |
|
|
2024
Q2 | $17.7M | Buy |
53,587
+1,153
| +2% | +$380K | 0.93% | 35 |
|
|
2024
Q1 | $20.7M | Buy |
52,434
+400
| +0.8% | +$158K | 1.09% | 32 |
|
|
2023
Q4 | $18.3M | Buy |
52,034
+243
| +0.5% | +$85.6K | 1% | 35 |
|
|
2023
Q3 | $19.4M | Sell |
51,791
-574
| -1% | -$215K | 1.17% | 27 |
|
|
2023
Q2 | $20M | Sell |
52,365
-1,021
| -2% | -$391K | 1.2% | 25 |
|
|
2023
Q1 | $18.5M | Buy |
53,386
+7,316
| +16% | +$2.53M | 1.16% | 25 |
|
|
2022
Q4 | $10.8M | Sell |
46,070
-3,780
| -8% | -$890K | 0.69% | 51 |
|
|
2022
Q3 | $12.3M | Buy |
49,850
+1,446
| +3% | +$356K | 0.88% | 43 |
|
|
2022
Q2 | $14.6M | Buy |
48,404
+47,130
| +3,699% | +$14.3M | 1.01% | 32 |
|
|
2022
Q1 | $523K | Buy |
1,274
+26
| +2% | +$10.7K | 0.03% | 202 |
|
|
2021
Q4 | $585K | Sell |
1,248
-245
| -16% | -$115K | 0.04% | 196 |
|
|
2021
Q3 | $634K | Hold |
1,493
| – | – | 0.04% | 181 |
|
|
2021
Q2 | $536K | Buy |
+1,493
| New | +$536K | 0.04% | 193 |
|